NBD AI Bulletin -- Walvax Biotechnology Co., Ltd (SZ 300142, close price: 37.33 yuan) pn September 27 announced that the Company will hold a general meeting on October 13, 2022.
In the first half of 2022, the operating income of Walvax Biotechnology mainly came from proprietary vaccines (98.93%).
Walvax Biotechnology Co Ltd's chairman is Li Yunchun, male, 60 years old, with an undergraduate degree. The president is Jiang Runsheng, male, 65 years old, with a doctoral degree.
As of press time, the market value of Walvax Biotechnology was 59.9 billion yuan.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.